To investigate how RBM17 is overexpressed in HCC cells, we identified RUNX1, DMRTC2, BACH2 and NFKB2 as potential transcription factors for RBM17 using data from the JASPAR website (http://jaspar.genereg.net/) and the UCSC website (http://genome.ucsc.edu/) (Fig. 7A). This evidence concerns the gene NFKB2 and hepatocellular carcinoma.